NBER Papers on Innovation Policy Working Group
2022 | ||
w29863 |
Ufuk Akcigit Ari Hyytinen Otto Toivanen |
A Year Older, A Year Wiser (and Farther from Frontier): Invention Rents and Human Capital Depreciation |
w29853 |
Song Ma |
The Education-Innovation Gap |
w29770 |
Kyle F. Herkenhoff Chenqi Zhu |
Patent Publication and Innovation |
w29733 |
Daniel Xu |
A Structural Empirical Model of R&D Investment, Firm Heterogeneity, and Industry Evolution |
w29721 |
Cathy Ge Bao Maggie X. Chen Junjie Hong Claudia Steinwender |
Omnia Juncta in Uno: Foreign Powers and Trademark Protection in Shanghai's Concession Era |
w29708 |
Yi Qian Hui Xie |
Addressing Endogeneity Using a Two-stage Copula Generated Regressor Approach |
w29676 |
Michal Zator |
Robots and Firm Investment |
w29654 |
Andrea Fosfuri Thomas Roende |
Caught In The Middle: The Bias Against Startup Innovation With Technical And Commercial Challenges |
w29644 |
Marcio Cruz Xavier Cirera Kyung Min Lee Jesica Torres |
Technology and Resilience |
2021 | ||
w29607 |
Song Ma |
Innovation Networks and Innovation Policy |
w29568 |
Holden A. Diethorn Gerald R. Marschke Andrew J. Wang |
STEM Employment Resiliency During Recessions: Evidence from the COVID-19 Pandemic |
w29552 |
Dimitris Papanikolaou Lawrence D. W. Schmidt Bryan Seegmiller |
Technology-Skill Complementarity and Labor Displacement: Evidence from Linking Two Centuries of Patents with Occupations |
w29515 |
Zhiguo He Jiasun Li |
An Economic Model of Consensus on Distributed Ledgers |
w29504 |
|
Technological Obsolescence |
w29456 |
William R. Kerr |
Winner Takes All? Tech Clusters, Population Centers, and the Spatial Transformation of U.S. Invention |
w29438 |
Craig Garthwaite Christopher Heard Bingxiao Wu |
The Economics of Medical Procedure Innovation |
w29422 |
Michael S. Dahl Petra Moser |
Mental Health, Creativity, and Wealth |
w29420 |
Bruce A. Weinberg |
Does Research Save Lives? The Local Spillovers of Biomedical Research on Mortality |
w29359 |
|
The Effects of Taxes on Innovation: Theory and Empirical Evidence |
w29354 |
Janet Gerson Jennifer Kuan |
Closing the Innovation Gap in Pink and Black |
w29267 |
Sendhil Mullainathan |
Fragile Algorithms and Fallible Decision-Makers: Lessons from the Justice System |
w29260 |
Sharon Belenzon Konstantin Kosenko Jungkyu Suh Yishay Yafeh |
The Rise of Scientific Research in Corporate America |
w29173 |
Heidi L. Williams |
Innovation: Market Failures and Public Policies |
w29008 |
Can Urgun Leeat Yariv |
Collective Progress: Dynamics of Exit Waves |
w28999 |
Tarek Alexander Hassan Aakash Kalyani Josh Lerner Ahmed Tahoun |
The Diffusion of Disruptive Technologies |
w28990 |
Daniel Fehder Yael Hochberg |
Innovation-Driven Entrepreneurship |
w28980 |
Amit Seru Nick Short Yuan Sun |
Financial Innovation in the 21st Century: Evidence from U.S. Patents |
w28978 |
Liran Einav Joseph Rashba Ran D. Balicer |
The Impact of Increased Access to Telemedicine |
w28964 |
Andrew W. Lo Richard T. Thakor |
Paying off the Competition: Market Power and Innovation Incentives |
w28942 |
Stefano DellaVigna Patricia Funk Nagore Iriberri |
Gender Differences in Peer Recognition by Economists |
w28915 |
Bhaven N. Sampat |
Crisis Innovation Policy from World War II to COVID-19 |
w28889 |
Amitabh Chandra Craig Garthwaite |
Regulatory Approval and Expanded Market Size |
w28880 |
Sharon Belenzon Matt Marx Dror Shvadron |
(When) Does Patent Protection Spur Cumulative Research Within Firms? |
w28858 |
Fabian Gaessler Matthew J. Higgins |
Market Size and Research: Evidence from the Pharmaceutical Industry |
w28856 |
Joy Tianjiao Tong Wei Wang |
Bankrupt Innovative Firms |
w28847 |
Shihe Fu Stephen Ross |
Agglomeration Economies and Race Specific Spillovers |
w28846 |
Scott Stern |
More than an Ivory Tower: The Impact of Research Institutions on the Quantity and Quality of Entrepreneurship |
w28839 |
Teresa C. Fort Christopher Goetz Nathan Goldschlag James Lawrence Elisabeth Ruth Perlman Martha Stinson T. Kirk White |
Redesigning the Longitudinal Business Database |
w28811 |
Joshua S. Gans Avi Goldfarb |
AI Adoption and System-Wide Change |
w28769 |
Adam B. Jaffe Margie E. Lachman |
Invention and the Life Course: Age Differences in Patenting |
w28768 |
Adam B. Jaffe Margie Lachman |
The Age of Invention: Matching Inventor Ages to Patents Based on Web-scraped Sources |
w28755 |
Rebecca Sachs Ariel Dora Stern |
Which Markets (Don't) Drive Pharmaceutical Innovation? Evidence From U.S. Medicaid Expansions |
w28748 |
Yuxiao Dong Kuansan Wang Dashun Wang Benjamin Jones |
Science as a Public Good: Public Use and Funding of Science |
w28713 |
|
Innovation and Human Capital Policy |
w28700 |
Jason Rathje John Van Reenen Jun Wong |
Opening up Military Innovation: Causal Effects of 'Bottom-Up' Reforms to U.S. Defense Research |
w28649 |
Bernhard Ganglmair Nicola Persico Timothy Simcoe Emanuele Tarantino |
Representation is Not Sufficient for Selecting Gender Diversity |
w28644 |
Larisa C. Cioaca |
Guaranteed Markets and Corporate Scientific Research |
w28588 |
Erik Brynjolfsson Wang Jin Sebastian Steffen Chi Wan |
Digital Resilience: How Work-From-Home Feasibility Affects Firm Performance |
w28587 |
|
The Repeated Setbacks of HIV Vaccine Development Laid the Groundwork for SARS-CoV-2 Vaccines |
w28562 |
Paula Stephan |
Uncertainty and Risk-Taking in Science: Meaning, Measurement and Management |
w28545 |
Mark Schankerman |
Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool |
w28544 |
David J. Deming Petra Moser |
Education and Innovation |
w28533 |
Sharon Belenzon Bernardo Dionisi |
First-mover Advantage and the Private Value of Public Science |
w28453 |
Joseph E. Stiglitz |
Artificial Intelligence, Globalization, and Strategies for Economic Development |
w28431 |
Wan-Ying Chang Bruce A. Weinberg |
Man Versus Machine? Self-Reports Versus Algorithmic Measurement of Publications |
w28379 |
Sean Nicholson June Pan Michael Waldman |
The Organization of Innovation: Property Rights and the Outsourcing Decision |
w28355 |
Janice C. Eberly Joshua L. Krieger Dimitris Papanikolaou |
Private and Social Returns to R&D: Drug Development and Demographics |
w28349 |
Lisa Larrimore Ouellette Heidi L. Williams |
Private and Public Investments in Biomedical Research |
w28335 |
Bhaven N. Sampat |
The Economics of Crisis Innovation Policy: A Historical Perspective |
w28325 |
|
Promoting Platform Takeoff and Self-Fulfilling Expectations: Field Experimental Evidence |
Generated on Sun Apr 24 00:00:03 2022